1. Home
  2. CVS vs BSX Comparison

CVS vs BSX Comparison

Compare CVS & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVS Health Corporation

CVS

CVS Health Corporation

HOLD

Current Price

$73.39

Market Cap

92.2B

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$62.57

Market Cap

103.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVS
BSX
Founded
1963
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.2B
103.6B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
CVS
BSX
Price
$73.39
$62.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
21
Target Price
$94.61
$104.48
AVG Volume (30 Days)
6.2M
13.4M
Earning Date
04-30-2026
04-22-2026
Dividend Yield
3.62%
N/A
EPS Growth
N/A
55.20
EPS
1.39
1.94
Revenue
$402,067,000,000.00
$9,076,000,000.00
Revenue This Year
$2.44
$12.02
Revenue Next Year
$4.47
$10.41
P/E Ratio
$52.89
$32.33
Revenue Growth
7.85
12.49
52 Week Low
$58.35
$61.25
52 Week High
$85.15
$109.50

Technical Indicators

Market Signals
Indicator
CVS
BSX
Relative Strength Index (RSI) 47.67 27.95
Support Level $72.97 N/A
Resistance Level $80.89 $76.77
Average True Range (ATR) 1.83 1.91
MACD 0.08 -0.38
Stochastic Oscillator 52.61 14.73

Price Performance

Historical Comparison
CVS
BSX

About CVS CVS Health Corporation

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: